ZA967915B - Therapeutic administration of hemoglobin in cardiac arrest - Google Patents

Therapeutic administration of hemoglobin in cardiac arrest

Info

Publication number
ZA967915B
ZA967915B ZA967915A ZA967915A ZA967915B ZA 967915 B ZA967915 B ZA 967915B ZA 967915 A ZA967915 A ZA 967915A ZA 967915 A ZA967915 A ZA 967915A ZA 967915 B ZA967915 B ZA 967915B
Authority
ZA
South Africa
Prior art keywords
hemoglobin
cardiac arrest
therapeutic administration
therapeutic
administration
Prior art date
Application number
ZA967915A
Other languages
English (en)
Inventor
Kenneth E Burhop
Moses S S Chow
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of ZA967915B publication Critical patent/ZA967915B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA967915A 1995-10-06 1996-10-06 Therapeutic administration of hemoglobin in cardiac arrest ZA967915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/540,115 US5733869A (en) 1995-10-06 1995-10-06 Therapeutic administration of hemoglobin in cardiac arrest

Publications (1)

Publication Number Publication Date
ZA967915B true ZA967915B (en) 1997-05-02

Family

ID=24154065

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA967915A ZA967915B (en) 1995-10-06 1996-10-06 Therapeutic administration of hemoglobin in cardiac arrest

Country Status (9)

Country Link
US (1) US5733869A (xx)
EP (1) EP0853485A4 (xx)
JP (1) JPH11512738A (xx)
AU (1) AU710496B2 (xx)
CA (1) CA2233917A1 (xx)
NO (1) NO981564D0 (xx)
TW (1) TW434022B (xx)
WO (1) WO1997012627A1 (xx)
ZA (1) ZA967915B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6213960B1 (en) * 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation
US6894150B1 (en) * 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US6670323B1 (en) * 1999-11-12 2003-12-30 Baxter International, Inc. Reduced side-effect hemoglobin compositions
IL153792A (en) * 2003-01-02 2007-08-19 Yissum Res Dev Co Method for increased production of hydroxyl radicals
US8805491B2 (en) * 2004-04-20 2014-08-12 Zoll Medical Corporation Microperfusive electrical stimulation
US9101779B2 (en) * 2006-10-19 2015-08-11 Uab Research Foundation Method and system for reducing cardiac low pressure states
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US9248093B2 (en) 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
CA3070172A1 (en) 2017-07-18 2019-01-24 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4757052A (en) * 1982-09-03 1988-07-12 Markov Angel K Method of preserving blood
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
FR2551660B1 (fr) * 1983-09-13 1986-11-14 Centre Nat Rech Scient Hemoglobine modifiee chimiquement, sa preparation, solutions aqueuses en contenant et leur utilisation
GB8328917D0 (en) * 1983-10-28 1983-11-30 Fisons Plc Blood substitute
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
ES2032802T5 (es) * 1986-11-10 2004-01-16 Biopure Corporation Sucedaneo de sangre semisintetico extrapuro.
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5268500A (en) * 1987-06-15 1993-12-07 Montefiore Medical Center Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
US4994444A (en) * 1987-07-31 1991-02-19 The Trustees Of Columbia In The City Of New York Macromolecules for sealing capillary endothelial junctions
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
IL87707A (en) * 1988-09-08 1994-06-24 Technion Inst For Research And Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
IL87708A (en) * 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
FR2640141B1 (fr) * 1988-12-14 1993-04-16 Merieux Inst Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
US5173426A (en) * 1989-10-06 1992-12-22 Yale University DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5386014A (en) * 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5248785A (en) * 1990-02-12 1993-09-28 Virginia Commonwealth University Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5432191A (en) * 1990-02-12 1995-07-11 The Center For Innovative Technology Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
US5306508A (en) * 1990-06-22 1994-04-26 The Regents Of The University Of California Red blood cell surrogate
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
US5413558A (en) * 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
AU2198592A (en) * 1992-02-20 1993-09-13 Alliance Pharmaceutical Corporation Inhibition of bacterial endotoxin
CA2074852A1 (en) * 1992-07-29 1994-01-30 Ehud Ilan Organ perfusion hemoglobins
EP0693924B2 (en) * 1993-02-22 2008-04-09 Abraxis BioScience, Inc. Methods for (in vivo) delivery of biologics and compositions useful therefor

Also Published As

Publication number Publication date
CA2233917A1 (en) 1997-04-10
JPH11512738A (ja) 1999-11-02
AU710496B2 (en) 1999-09-23
AU6853196A (en) 1997-04-28
TW434022B (en) 2001-05-16
WO1997012627A1 (en) 1997-04-10
NO981564L (no) 1998-04-06
US5733869A (en) 1998-03-31
EP0853485A4 (en) 2000-11-02
EP0853485A1 (en) 1998-07-22
NO981564D0 (no) 1998-04-06

Similar Documents

Publication Publication Date Title
AU1805499A (en) Method and apparatus for delivery of therapeutic agents to the heart
AU2326892A (en) Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
ZA967915B (en) Therapeutic administration of hemoglobin in cardiac arrest
PL321741A1 (en) Bicyclic derivatives of isothiourea useful in medical therapy
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HUP9900147A3 (en) Therapeutic agents and autoimmune diseases
PL336760A1 (en) Treatment of skin diseases
GB9318853D0 (en) Improvements in relation to medical diathermy
PL311031A1 (en) Use of concentrates comprising vwf in complex therapy in case of treatment by using anticoagulants and fibrinolitic drugs
ZA968054B (en) Therapeutic use of hemoglobin in promoting wound healing
PT879054E (pt) Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
AU5201793A (en) Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
EP0370115A4 (en) Catheter for diagnosis and therapy
AU7011098A (en) Treatment of adverse effects associated with administration of extracellular hemoglobin
AU2623088A (en) New anti-receptor peptides and therapeutic agents
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
GB2220652B (en) Treatment of pastures
HK1005735A1 (en) Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
GB9216360D0 (en) Treatment of blood
ZA936136B (en) Treatment of skin diseases
IL108342A0 (en) Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic application
GB8825464D0 (en) Electro therapy chair for treatment of various dermatological & rheumatological diseases
ZA964518B (en) Benzimidazole derivatives their preparation and their therapeutic use